drugset / Trial / NCT03292445

Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

NCT03292445

NaSingle-groupOpen-labelTreatment

Summary

This research study is to determine if donor blood stem cells given after living, related, HLA antigen (Ag) haplotype match or living, unrelated donor kidney transplantation. Minimal HLA antigen matching will include matching of 2 HLA antigens that can be either HLA A, B, and /or DR. This research will change the immune system such that immunosuppressive drugs can be completely withdrawn or reduced to minimal dose without kidney rejection.

Timeline

Start
2017-02-14
Primary completion
2022-02-14
Completion
2024-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Donor blood stem cells Unknown 1e+07 cells/kg
Subject T cells Cell therapy 1.5e+08 cells/kg

Indications

No indication recorded.